Understanding how to improve speech ability in children with Down Syndrome
Predictors of Speech Ability in Children with Down Syndrome
This study is looking at what helps kids with Down Syndrome, ages 7 to 12, improve their speech skills, so they can communicate better, and it will use a special program to help them along the way.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-10316884 on NIH RePORTER |
What this research studies
This research investigates the factors that influence speech ability in children with Down Syndrome, focusing on children aged 7 to 12 years. The study will measure speech articulation accuracy and intelligibility, along with cognitive and vocabulary skills, to identify predictors of speech development. A validated speech intervention will be employed to enhance speech intelligibility, allowing researchers to evaluate changes over time. By understanding these predictors, the research aims to inform future interventions that can help children communicate more effectively.
Who could benefit from this research
Good fit: Ideal candidates for this research are children aged 7 to 12 years diagnosed with Down Syndrome.
Not a fit: Patients outside the age range of 7 to 12 years or those without a diagnosis of Down Syndrome may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved speech communication skills for children with Down Syndrome, enhancing their educational and social experiences.
How similar studies have performed: Previous research has shown success with similar speech intervention approaches, indicating potential for meaningful advancements in this area.
Where this research is happening
Nashville, United States
- Vanderbilt University Medical Center — Nashville, United States (Active)
Researchers
- Principal investigator: Camarata, Stephen Mark — Vanderbilt University Medical Center
- Study coordinator: Camarata, Stephen Mark
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.